APA (7th ed.) Citation

J, H. (2023). Pharmacokinetics and Safety of Group A and B Anti-Tuberculosis Drugs Used in Treatment of Rifampicin-Resistant Tuberculosis during Pregnancy and Post-Partum: A Narrative Review. Pathogens (Basel, Switzerland), 12(12), . https://doi.org/10.3390/pathogens12121385

Chicago Style (17th ed.) Citation

J, Hughes. "Pharmacokinetics and Safety of Group A and B Anti-Tuberculosis Drugs Used in Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and Post-Partum: A Narrative Review." Pathogens (Basel, Switzerland) 12, no. 12 (2023). https://doi.org/10.3390/pathogens12121385.

MLA (9th ed.) Citation

J, Hughes. "Pharmacokinetics and Safety of Group A and B Anti-Tuberculosis Drugs Used in Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and Post-Partum: A Narrative Review." Pathogens (Basel, Switzerland), vol. 12, no. 12, 2023, https://doi.org/10.3390/pathogens12121385.